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Abstract
Background: Whole-heart first-pass perfusion cardiovascular magnetic resonance (CMR) relies on highly accelerated
image acquisition. The influence of undersampling on myocardial blood flow (MBF) quantification has not been
systematically investigated yet. In the present work, the effect of spatiotemporal scan acceleration on image
reconstruction accuracy and MBF error was studied using a numerical phantom and validated in-vivo.
Methods: Up to 10-fold scan acceleration using k-t PCA and k-t SPARSE-SENSE was simulated using the MRXCAT CMR
numerical phantom framework. Image reconstruction results were compared to ground truth data in the k-f domain
by means of modulation transfer function (MTF) analysis. In the x-t domain, errors pertaining to specific features of
signal intensity-time curves and MBF values derived using Fermi model deconvolution were analysed. In-vivo first-pass
CMR data were acquired in ten healthy volunteers using a dual-sequence approach assessing the arterial input
function (AIF) and myocardial enhancement. 10x accelerated 3D k-t PCA and k-t SPARSE-SENSE were compared
and related to non-accelerated 2D reference images.
Results: MTF analysis revealed good recovery of data upon k-t PCA reconstruction at 10x undersampling with
some attenuation of higher temporal frequencies. For 10x k-t SPARSE-SENSE the MTF was found to decrease to
zero at high spatial frequencies for all temporal frequencies indicating a loss in spatial resolution. Signal intensity-time
curve errors were most prominent in AIFs from 10x k-t PCA, thereby emphasizing the need for separate AIF acquisition
using a dual-sequence approach. These findings were confirmed by MBF estimation based on AIFs from fully sampled
and undersampled simulations. Average in-vivo MBF estimates were in good agreement between both accelerated
and the fully sampled methods. Intra-volunteer MBF variation for fully sampled 2D scans was lower compared to
10x k-t PCA and k-t SPARSE-SENSE data.
Conclusion: Quantification of highly undersampled 3D first-pass perfusion CMR yields accurate MBF estimates
provided the AIF is obtained using fully sampled or moderately undersampled scans as part of a dual-sequence
approach. However, relative to fully sampled 2D perfusion imaging, intra-volunteer variation is increased using
3D approaches prompting for further developments.
Keywords: First-pass myocardial perfusion, Myocardial blood flow, Modulation transfer function, k-t PCA, k-t
SPARSE-SENSE, 3D-MTF, Whole-heart perfusion
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Background
Diagnosis of ischemia in patients with known or sus-
pected coronary artery disease (CAD) is increasingly be-
ing performed using cardiovascular magnetic resonance
(CMR) first-pass perfusion imaging. Perfusion CMR out-
performs other imaging techniques such as positron
emission tomography (PET) and single photon emission
computed tomography (SPECT) in terms of spatial reso-
lution and operates without ionizing radiation. Compared
to coronary angiography and the assessment of fractional
flow reserve, perfusion CMR is non-invasive and has been
proven suitable for patients with intermediate probability
of significant CAD [1]. Numerous authors have compared
the diagnostic performance of perfusion CMR to SPECT
[2–6] and PET [7–10], and found that CMR performs
at least comparably to these methods [11]. Studies
comparing perfusion CMR to stress echocardiography
and perfusion computed tomography report similar
results [12–14].
Detection of small ischemic regions such as sub-
endocardial perfusion defects is enabled by the high
spatial resolution offered by CMR [15]. In addition to
sufficient spatial resolution, whole-heart coverage is
desired to accurately assess the size and extent of per-
fusion deficits [16]. These demands have triggered the
development of three-dimensional (3D) scanning tech-
niques employing advanced undersampling strategies
for efficient data acquisition [17–19]. The importance
of whole-heart imaging has further been stressed by
authors evaluating the volumetric ischemic burden as
a marker of significant CAD [20–22]. Optimization of
scanning efficiency has also been made in the temporal
domain. Multiple authors have proposed perfusion
CMR throughout the cardiac cycle to assess differences
in perfusion between heart phases and to combine cine
and perfusion imaging into a single scan [23–25]. Alterna-
tively, interleaved acquisition at different heart phases may
be used to separately capture blood pool and myocardial
enhancement for improved perfusion quantification
[26, 27] or frame-by-frame T1 mapping [28].
Absolute quantification of perfusion CMR has gained
significant attention in the past decade since clinical
advantages have been pointed out [29, 30]. Several tech-
nical aspects of myocardial blood flow (MBF) estimation
from reconstructed images have been investigated
mostly using single or multi-slice 2D imaging. Special
focus has been put on the development of mathematical
models for MBF estimation [31–34] and comparison
between them [35, 36]. Zarinabad et al. have compared
voxel-wise vs. spatially averaged (sector-wise) estimation
of MBF [36] and highlighted the importance of accurate
bolus arrival time estimation [37]. Most recently, the
feasibility of 3D CMR perfusion quantification has been
demonstrated [25, 27].
Perceived image quality and deviation from a fully
sampled reference image have traditionally been used
as direct measures to validate spatiotemporal scan
acceleration methodology [38–40]. A more general
approach is the use of the modulation transfer function
(MTF) concept to characterize the ability of a MR system
to correctly capture spatial and temporal frequencies [41].
A perturbation of the system combined with linear regres-
sion is used yielding the MTF derived from the slope, and
an artefact map based on the ratio of slope and intercept
of the linear fit. This method is well suited for linear
reconstruction methods, but application to non-linear
reconstruction techniques such as compressed sensing is
also feasible if linearization about a suitable expansion
point is used. Consequently, the MTF approach can be
employed to compare spatiotemporal performance of
linear and non-linear reconstruction algorithms, such as
k-t PCA and k-t SPARSE-SENSE [42, 43].
The present study introduces a linearized MTF
approach to evaluate k-t PCA and k-t SPARSE-SENSE in
the context of highly accelerated, fully quantitative 3D
myocardial perfusion imaging. MTF maps derived from
numerical phantoms and in-vivo data are used to inves-
tigate changes of spatiotemporal fidelity introduced by
undersampling. Furthermore, errors in signal intensity-
time curves are analysed and their influence on MBF
estimation is highlighted. MRXCAT simulation of a sub-
endocardial lesion reveals the ability of the proposed
methodology to identify small ischemic territories.
Finally, simulation results are validated in-vivo compar-
ing 3D k-t PCA, 3D k-t SPARSE-SENSE and fully sam-
pled 2D imaging.
Theory
k-t PCA and k-t SPARSE-SENSE
k-t PCA and k-t SPARSE-SENSE are reconstruction
methods based on differing principles both suited for
highly accelerated MRI.
In k-t PCA, data is acquired on a Cartesian grid, which
is shifted in k-space for each time frame as in k-t SENSE
[38]. The centre of k-space is fully sampled in all time
frames, providing an image series with low spatial and
high temporal resolution termed as training data. Before
further processing, the data matrix D originally acquired
in k-t space is Fourier transformed to the x-f domain,
P ¼ Fk−t→x−fD: ð1Þ
Fk-t→x-f denotes the Fourier transform from k-t to x-f
space. The training data are used to determine the tem-
poral principal components (PCs) of the dataset by
transforming data from x-f space to x-pc space using
principal component analysis (PCA),
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P ¼ WB; ð2Þ
where P and W are matrices representing the data in x-f
and x-pc space, respectively, and matrix B contains the
PCs. By assuming spatial invariance of the PCs, the same
PCs can be used to unfold the aliased data. The recon-
struction problem can then be solved via [42]
wx ¼ M2EH EM2EH þ λΨ
 †
palias; x; ð3Þ
where wx and px are vectors representing the rows of W
and P at position x. wx contains the weights of the
aliased voxels in palias,x, M
2 is the signal covariance, Ψ
indicates the noise variance, and E is the encoding
matrix. The dagger represents the Moore-Penrose
pseudoinverse and superscript H the conjugate trans-
pose. The reconstructed image ix-f in x-f space is
obtained using
ix−f ¼ Bx†wx ð4Þ
followed by Fourier transformation to the x-t domain.
In contrast to k-t PCA, data in k-t SPARSE-SENSE are
pseudo-randomly undersampled with a higher sampling
density near the k-space centre decreasing towards the
edge [44]. The reconstruction problem reads
argmin
i
∥d−Ei∥22 þ λ∥Φi∥1; ð5Þ
with the encoding matrix E as above, the data d
expressed as a vectorised form of D, and i the image to
be reconstructed. Φ represents a sparsifying transform
and λ is the regularization parameter. In k-t SPARSE-
SENSE, the reconstruction equation is minimized using
a POCS-like algorithm alternating between data
consistency and soft-thresholding [45, 46] leaving the
acquired data unchanged, or non-linear conjugate gra-
dient optimization [44]. Common choices for Φ
include the temporal Fourier transform (FT), temporal
PCA or a mixture of both starting with the temporal
FT for the first iterations, followed by PCA for the
remaining iterations [47].
Spatiotemporal modulation transfer functions
Traditionally, modulation transfer functions (MTF) are
used to describe an imaging system’s ability to portray
an object. Chao et al. [41] have adopted the concept for
the evaluation of accelerated MRI. The relationship be-
tween the object ρ and its image i can be formulated as
i ¼ Hρþ n; ð6Þ
with the modulation transfer function H and noise n.
Explicit calculation of H for large imaging problems,
such as dynamic 3D imaging, can be infeasible or
computationally too expensive. To address this issue, a
perturbation approach
iξ ¼ HBðρþ ξÞ þ hA ¼ HBρξ þ hA ð7Þ
can be used. A small perturbation ξ is added repeatedly
to the object ρ. ρξ and iξ are the perturbed object and
image, respectively. HB and hA are analogous to the
MTF and noise in eq. (6). Multiple realizations of eq. (7)
with different perturbations can be solved for hA and HB
using linear regression, which results in slope HB and
intercept hA. This MTF formalism can be applied to
study the effects of scan acceleration. To this end, the
image iR=1 reconstructed from fully sampled data is used
as the true object and the reconstructed image iR>1 from
undersampled data is its imaged version. The adapted
version of eq. (7) reads
iR>1 ¼ HBiR¼1 þ hA: ð8Þ
Instead of the 2D MTF [41], a 3D MTF HB(ky,kz,f )
portraying two spatial and the temporal frequency direc-
tions is necessary for Cartesian dynamic 3D imaging.
The frequency encoding direction kx can be omitted, or
used for averaging, since no undersampling is applied
and thus the MTF is constant along this direction. The
MTF can be computed as [41]
MTF ky; kz; f
  ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
x HB x; ky; kz; f
  2
Nx
vuut
; ð9Þ
where Nx is the number of readout profiles. Similarly,
the signal-to-artefact map (S2A) can be derived relating
the MTF to the intercept of the linear regression and to
the object itself:
S2Aðky; kz; f Þ ¼ MTFðky; kz; f Þ⋅
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
x jρðx; ky; kz; f Þj2P
x jhAðx; ky; kz; f Þj2
s
:
ð10Þ
While the formalism is directly valid for the linear k-t
PCA in eq. (3), for k-t SPARSE-SENSE (eq. (5)) an
approximately linear relationship between fully sampled
and accelerated imaging is assumed based on linearization
about a suitable expansion point. This expansion point
corresponds to the magnitude of the unperturbed object
at each position in ky-kz-f space.
In the original interpretation of the MTF formalism a
true object and its imaged version are compared. The
natural upper bound for the MTF is 1, indicating that a
certain voxel in k-f space perfectly reproduces the corre-
sponding object part. Lower values of the MTF indicate
image degradation by the imaging system. Note that this
strict physical constraint not necessarily applies to scan
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acceleration. Especially at the k-f-space edges, where the
signal-to-noise ratio (SNR) is low, the effect of under-
sampling and subsequent reconstruction might also
increase k-f space magnitudes, resulting in MTF values
above 1. Therefore, only the central k-f-space parts of
the MTF should be evaluated.
Myocardial blood flow quantification
There are a number of methods estimating myocardial
blood flow (MBF) from first-pass perfusion CMR. The
most direct approach is to derive MBF estimates from
the relationship between contrast agent concentrations
at the inlet cAIF(t), referred to as arterial input function
(AIF), and in the myocardial tissue cMYO(t), using [48].
cMYO tð Þ ¼ RF tð Þ⊗cAIF tð Þ: ð11Þ
The flow-weighted impulse response function RF = F ·
R(t) comprises the MBF estimate F and a normalized,
decaying function R, with RF(t = 0) = F. The impulse
response function can either be explicitly computed by
model-free deconvolution, or approximated using a suit-
able mathematical representation. The most common
choice for RF is approximation using the 3-parameter
Fermi model [27, 31],
RF tð Þ ¼ F  1þ β1þ βeαt : ð12Þ
In this equation, F is the MBF estimate, and α, β are
further fitting parameters. Note that the units of meas-
urement for cAIF(t) and cMYO(t) are mmol/mL, while the
amount of contrast agent in the myocardium measured
by indicator dilution theory is in units of mmol/g of tis-
sue. This discrepancy is implicitly corrected by scaling F
by the myocardial tissue density of 1.05 g/mL [49].
Methods
In-vivo measurements
In-vivo CMR experiments were performed in 10 healthy
volunteers (4 males) on a Philips Achieva 1.5 T scanner
(Philips Healthcare, Best, The Netherlands) using a 5-
channel cardiac coil array. Volunteers had an average
age of 26.2 ± 4.7 years and underwent CMR upon writ-
ten informed consent in accordance with ethics regula-
tions approved by the local ethics committee. Dynamic
contrast enhanced CMR was conducted twice per volun-
teer and at least 20 min apart. Gadobutrol (Gadovist,
Bayer Schering Pharma, Germany) at 0.075 mmol/kg
b.w. dose was injected as contrast agent, followed by a
30 mL saline flush at 4 mL/s. Volunteers were measured
during instructed breath-holding.
A saturation-recovery dual-sequence spoiled gradient
echo sequence with ECG-triggering was used to acquire
one image pair per heartbeat. The interleaved acquisitions
[50] consisted of a 2D aortic scan for arterial input func-
tion (AIF) assessment and an end-systolic left-ventricular
scan to capture myocardial enhancement, as proposed
earlier [27]. Myocardial enhancement was assessed using
3D imaging accelerated by k-t PCA (N = 7 measurements),
k-t SPARSE-SENSE (N = 7), and fully sampled single-slice
2D imaging (N = 6) for comparison. To limit the amount
of contrast agent administered and the examination time
per volunteer, only two injections per volunteer were car-
ried out. This resulted in three groups of volunteers,
allowing comparison of k-t PCA or k-t SPARSE-SENSE
with fully sampled 2D imaging (N = 3 for both), and
direct inter-comparison between the accelerated se-
quences (N = 4).
All myocardial enhancement scans were run with
WET saturation preparation [51] using a saturation to
acquisition time (TSAT) of 150 ms. Accelerated 3D im-
aging parameters were: nominal scan acceleration: 10x,
net acceleration factor without partial Fourier: 7.4–7.8,
11×7 training profiles in ky and kz, spatial resolution:
2.3×2.3×10 mm3, 10 contiguous slices, typical field-of-
view: 320×320×80 mm3, flip angle: 15°, acquisition win-
dow: 189–216 ms, TR: 1.89–1.93 ms, TE: 0.74–0.78 ms.
62.5% and 75% partial Fourier sampling was applied in
frequency and in both phase encoding directions,
respectively. An elliptical k-space shutter was used on
both the undersampled grid and the training portion.
Equal undersampling rates were used in k-t PCA and k-t
SPARSE-SENSE. Examples of sampling patterns as
applied in-vivo for both k-t methods are illustrated in
Fig. 1. Fully sampled 2D myocardial enhancement scans
were run with the following parameters: spatial reso-
lution: 2.3×2.3 mm2 in-plane, slice thickness: 10 mm, flip
angle: 15°, acquisition window: 188–225 ms. TR, TE and
partial Fourier factors were the same as for 3D imaging,
resulting in comparable acquisition windows.
2D AIF imaging was planned orthogonally to the
ascending aorta in transverse view, with a separate
WET saturation preparation pulse. An ultrashort TSAT
of 3.7 ms was enabled using a central-out profile order,
i.e. acquisition started at the k-space centre, continued
outwards and concluded at the most distant point from
the centre. Further 2D scan parameters were: 3x k-t
PCA acceleration, 11 training profiles, spatial reso-
lution: 3.5×3.5 mm2, slice thickness: 10 mm, field-of-
view: 260×300 mm2, flip angle: 15°, acquisition window:
40–48 ms, TR: 1.67 ms, TE: 0.58 ms.
In addition to contrast-enhanced imaging, baseline T1
values were measured in all volunteers using modified
Look-Locker inversion recovery (MOLLI) imaging [52].
MOLLI acquisitions were done before the first and second
contrast administration. Population average pre-contrast
myocardial and left-ventricular T1 values for the first and
second injection were determined from these MOLLI T1
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maps. These average T1 values were subsequently used for
signal intensity to contrast agent concentration conver-
sion, as outlined below.
Image reconstruction
k-t PCA and k-t SPARSE-SENSE reconstructions were
implemented in ReconFrame (Gyrotools LLC, Zurich,
Switzerland) and Matlab R2014a (MathWorks, Natick
MA, USA). Sensitivity maps were derived from a separ-
ately acquired reference scan. The k-t SPARSE-SENSE
implementation comprised soft thresholding and a com-
bination of temporal FT (10 iterations) and PCA (iteration
11 onwards) as sparsifying transforms [47]. Reconstruc-
tion voxel sizes of 2×2 mm2 and 1.25×1.25×5 mm3 were
achieved using zero-filling of the 2D AIF image and the
accelerated 3D scan, respectively. All reconstructed in-
vivo images were manually segmented to yield regional
signal intensity-time curves.
Modulation transfer function analysis
Numerical simulations were performed to compare
images reconstructed from undersampled data with fully
sampled references using MTFs. A fully sampled 3D
numerical phantom was created using the MRXCAT
simulation framework [53]. Phantom parameters were:
spatial resolution: 2.3×2.3 mm2, slice thickness: 5 mm,
10 slices, TR/TE: 2.0/1.0 ms, flip angle: 15°, contrast agent
dose: 0.075 mmol/kg b.w., 5 receive coils, myocardial
blood flow (MBF): 1 mL/g/min. 64 noise realizations with
equal noise statistics were performed, each comprising 11
different perturbations for 4 different acceleration factors
(cf. below). In each realization, 11 identical datasets
were generated, which were individually perturbed by
multiplication with factors 0.95–1.05 in steps of 0.01,
and subsequent degradation by noise (SNR = 20). Scaling
was done to ensure that a certain signal intensity range
was covered for linear regression analysis. Compared to
completely random perturbations without scaling, this
approach ensured a spread of signal values at every k-
space position. This resulted in a drastically reduced
number of iterations required to probe linearity at all
spatiotemporal frequency positions.
Fully sampled and undersampled numerical phantoms
were reconstructed using k-t PCA and k-t SPARSE-
SENSE. Undersampling factors were 2, 5 and 10 excluding
training data, corresponding to net factors of 1.9, 4.4, and
7.6 when including the central 11×7 training ellipse.
Because of a steep decline of k-space magnitudes away
from the centre, noise becomes dominant towards the
edges of k-space. To mitigate this effect, 64 realizations of
each set of simulations were done and the average recon-
structed images were used for MTF analysis. The recon-
structed images from undersampled data were compared
to the fully sampled reference in k-f space using linear
regression as detailed in eq. (8). MTFs and corresponding
artefact measures were computed (cf. eqs. (9), (10)). To
account for the drastic decrease of data magnitudes
towards the k-space edges, MTFs were masked using
thresholding on corresponding signal-to-artefact maps
(S2A). The S2A threshold was empirically set to 3 for 3D
MTF maps; a value which best separates parts of the MTF
with low and high artefact proportion. The different steps
employed for MTF analysis are illustrated in Fig. 2.
Timing constraints prohibit acquisition of a fully sam-
pled 3D dataset during the first-pass of the contrast
agent in-vivo. Hence, reference single slice 2D data were
Fig. 1 3D k-space sampling patterns in ky-kz for k-t PCA (a) and k-t SPARSE-SENSE (b). The regular undersampling pattern in k-t PCA is shifted
along the temporal dimension using a fixed pattern. In k-t SPARSE-SENSE the sampling is random with high sampling probability density in the
k-space centre decreasing towards the edge. The randomness ensures temporal variability of the sampling pattern. 75% partial Fourier sampling
was employed along ky and kz in both cases
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used for in-vivo MTF analysis. MTF calculations were
performed using the same undersampling factors and
procedure as for the MRXCAT phantom. In contrast to
the MRXCAT case, training consisted of 11 profiles in ky
only, resulting in different net acceleration factors (1.9,
3.8, and 5.9), and the S2A threshold was set to 2.5.
Image-time domain analysis
In addition to MTF analysis in k-f space, signal intensity
vs. time curves extracted from MRXCAT images were
investigated. Direct comparison of accelerated scanning
simulations with fully sampled reference data allows for
estimation of data fidelity upon undersampling during
contrast enhancement. Furthermore, specific features of
the signal intensity-time curve such as the pre-contrast
baseline, peak enhancement and upslope can be com-
pared. Errors in these features will directly propagate
into the estimated myocardial blood flow upon signal-
to-concentration conversion or deconvolution fitting.
Myocardial blood flow quantification
Estimation of myocardial blood flow (MBF) was per-
formed in two steps. First the image signal intensity vs.
time curves from the blood pool and myocardium were
converted to concentration vs. time curves using the
signal model of the form [31]
S ¼ S0 
 
1− exp −R1 TSATð Þð Þ  an−1 þ 1− exp −R1 TRð Þð Þ  1−a
n−1
1−a
!
:
ð13Þ
S represents the signal intensity, TSAT the saturation
delay, TR the repetition time and n the number of pro-
files acquired between the acquisition start and the cen-
tral k-space portion. R1 = 1/T1 is the dynamic relaxivity
and the term a = cos α · exp(−R1TR) additionally contains
the flip angle α. The baseline time frames were used to
determine the scaling factor S0 using pre-contrast T1
values. These values were either known for the MRXCAT
simulations, or measured using MOLLI imaging for in-
vivo data. Since S0 can be assumed unaffected by the
Gadolinium administration, the dynamic T1 can be cal-
culated with this S0 for each time frame. The relaxivity
R1 is given by
R1 ¼ 1T 1 ¼
1
T 1;0
þ cr; ð14Þ
where T1,0 is the baseline T1 in the absence of contrast
agent, and r the material-specific relaxivity of the con-
trast agent. Resolving eq. (14) yields the concentration c
of the contrast agent.
Baseline ranges for signal-to-concentration conversion
were set to time frames 1–5 for the AIF and 1–10 for
the myocardial curves in all MRXCAT simulations. Since
baseline length, timing of acquisition and contrast agent
injection vary in-vivo, baseline range selection was done
manually in each volunteer dataset. In-vivo population
average pre-contrast T1,0 values derived from MOLLI
imaging were: 1590 ms for the left ventricle and
1020 ms for the myocardium at the first contrast agent
injection. T1,0 before the second injection were 640 ms
and 680 ms, respectively.
In a second step, the concentration vs. time curves
cAIF and cMYO from the blood pool and the myocardium,
respectively, were related to estimate the MBF using
Fermi model deconvolution as detailed in eqs. (11) and
(12), and reference [27].
Fig. 2 Workflow for the simulation of modulation transfer functions
(MTFs). Image reconstruction is repeated for R undersampling factors,
n times, and for p different perturbations. The reconstruction results are
averaged over the realizations, and Fourier transformed along the
frequency encode direction, since no undersampling is applied in this
direction. Linear regression yields the maps hA and HB for calculation
of the MTF and the signal-to-artefact maps. Finally, signal-to-artefact
maps are used to mask the MTF results
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Sub-endocardial Ischemic lesion simulation
The ability of the proposed 3D methods to reveal small
ischemic defects was probed by MRXCAT simulation of
sub-endocardial ischemia. Ischemia was introduced in a
single slice of the MRXCAT phantom with a healthy rest
MBF of 1 mL/g/min. The ischemic region in a mid-
ventricular slice covered a circumferential lateral sector
spanning 60°, and a transmural sub-endocardial layer of
1–2 voxels. In this ischemic territory, contrast enhance-
ment was suppressed such that the signal intensities
remained around the baseline level during all time frames.
Ischemic MRXCAT data were reconstructed without
undersampling and at 10x scan acceleration using both k-t
PCA and k-t SPARSE-SENSE. Subsequently, MBF quanti-
fication was performed.
Results
MTF simulation results are shown in Fig. 3. Thresholds
in signal-to-artefact maps (S2A) were used to mask out
regions with low SNR in MTF maps. 3D and 2D MTF
maps were set to zero if the corresponding signal-to-
artefact values were below 3 and 2.5, respectively. For
3D MRXCAT the MTF spans a 3D space in ky-kz-f.
Figure 3a displays a ky-f slice of the MRXCAT MTF
map at kz = 0 for k-t PCA and k-t SPARSE-SENSE at
nominal acceleration factors of 2, 5, and 10. A kz-f slice
at ky = 0 of the MRXCAT MTFs is shown in Fig. 3b. For
both reconstruction methods at all acceleration factors,
the non-zero MTF values lie around the main axes, i.e.
along the different direct current (DC) regions. In the
temporal DC region, data at most spatial frequencies ky
and kz are partially restored upon undersampling. Simi-
larly, at spatial DC, all temporal frequency components
are restored to a certain degree. MTF values decrease
with increasing distance from the DC axes. For k-t PCA
at different undersampling factors, the shape of the
MTF remains similar with slight narrowing of the non-
zero regions near the DC axes. At R = 10, the MTF is
noisier than at lower acceleration indicating noise ampli-
fication at certain spatiotemporal frequencies. Compared
to k-t SPARSE-SENSE, k-t PCA restores off-DC tem-
poral frequencies on a relatively narrow range. As a con-
sequence, MTFs from k-t SPARSE-SENSE have a larger
non-zero area, but exhibit larger changes when increasing
R. MTF values >1 away from the DC axes signify deviation
from linear behaviour due to the non-linearity of the
reconstruction algorithm. A number of spatial frequency
Fig. 3 Modulation transfer function (MTF) simulation results comparing k-t PCA and k-t SPARSE-SENSE. MTFs for undersampling factors 2, 5 and
10 are shown in the three rows. a,b MTF maps using the MRXCAT numerical phantom plotted along ky-f at kz = 0 (a), and along kz-f at ky = 0 (b). c
MTF ky-f maps derived from fully sampled 2D in-vivo data with retrospective undersampling. MTF maps were masked using an empirically
determined threshold in the signal-to-artefact maps. Thresholds were set to 3 for 3D MRXCAT, and 2.5 for 2D in-vivo simulations
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components along ky is not restored using 10x k-t
SPARSE-SENSE. This leads to a loss of in-plane spatial
resolution in the reconstructed image.
MTF results derived from 2D in-vivo data are illus-
trated in Fig. 3c, revealing similar patterns as for the 3D
simulation along the DC axes. In contrast to 3D, 2D
results exhibit lower signal-to-artefact ratios, yielding
smaller non-zero MTF areas despite the slightly reduced
signal-to-artefact threshold. As in the 3D simulation at
maximum undersampling rate R = 10, k-t SPARSE-
SENSE exhibits a loss of spatial resolution in phase-
encoding direction.
AIFs extracted from central left-ventricular regions of
the reconstructed 3D MRXCAT images for R = 1, 2, 5,
10 are presented in Fig. 4a,b. AIFs appear perfectly
aligned for all R except for the baseline. A close-up of
the baselines and corresponding error plot as a function
of R reveals 16.5 ± 2.0% reduced baseline signal inten-
sities at R = 10 for k-t PCA compared to the reference,
while the baseline error is – 4.1 ± 1.4% for 10x k-t
SPARSE-SENSE (Fig. 4c,d). Errors in the AIF upslope
and maximum signal intensity are depicted in Fig. 4e,f,
and remain below ±2% at all acceleration factors.
Figure 5 highlights myocardial signal intensity-time
curves extracted from a septal segment at a mid-
ventricular level of 3D MRXCAT simulations. Reference
(R = 1) and R = 2, 5, 10 undersampled acquisitions are
shown. Overall agreement between curves at all acceler-
ation factors is good. Baseline errors are visible at R = 10
for both reconstruction methods, with increased signal
intensity in the first time frames for k-t PCA, and an ele-
vated baseline shortly before bolus arrival for k-t
SPARSE-SENSE. As Fig. 5c reveals, these errors almost
cancel out by averaging the baseline across the first 10
time frames. Mean baseline errors and standard devia-
tions for 10 realizations of the simulations and 10-fold
undersampling were 1.4 ± 4.3% for k-t PCA and 2.4 ±
2.4% for k-t SPARSE-SENSE. The myocardial upslope
changes by – 0.9 ± 1.0% and – 9.4 ± 3.4% for 10x k-t
PCA and SPARSE-SENSE, respectively. The peak signal
intensity error stays below ±2% at all undersampling
factors.
Errors in estimated MBF were evaluated in 8 slices
and 6 angular sectors of the 3D MRXCAT simulation
with an AIF extracted from the undersampled image
representing standard non-interleaved acquisition. In
Fig. 4 Arterial input functions (AIFs) derived from 3D MRXCAT simulations for different undersampling factors and signal intensity errors. AIFs
from reconstructions using (a) k-t PCA and (b) k-t SPARSE-SENSE for fully sampled reference, and undersampling factors R = 2, 5, 10. Baseline
(dashed red) and upslope limits (solid blue) are indicated in (a,b). c Zoom of the AIF baselines in (a), (b) as indicated by the dashed boxes. d-f
Percentage error as a function of the undersampling factor in (d) baseline, (e) upslope and (f) peak signal. Error bars indicate mean and twice the
standard deviation across 10 realizations of the simulation
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order to model interleaved scanning with separate AIF
assessment, MBF quantification errors were also deter-
mined using an AIF derived from a fully sampled refer-
ence. Detailed results are depicted in the form of Bull’s
eye plots in Fig. 6, and summarized in Fig. 7 as mean
MBF errors and standard deviations across the 8×6 re-
gions. Mean MBF errors remain below 3% for all evalua-
tions at R = 2 and R = 5. In contrast, if the AIF is
extracted from the undersampled data itself, MBF at 10x
undersampling is underestimated by 43.1 ± 2.3% for k-t
PCA, and 15.6 ± 6.2% for k-t SPARSE-SENSE. Underesti-
mation is removed when the AIF from fully sampled
data is employed for quantification, with average MBF
errors of 0.8 ± 4.3% and 0.9 ± 7.9% for 10x k-t PCA and
k-t SPARSE-SENSE, respectively. The variation of MBF
errors across the myocardium rises alongside increasing
the acceleration factor.
Figure 8 displays example MRXCAT images of healthy
and diseased simulations. While in the healthy case
dynamic contrast enhancement is homogeneous in all
myocardial slices, a small sub-endocardial defect was
introduced in the lateral segment of the mid-ventricular
slice of the ischemia simulation. The ischemic lesion is
very distinct in the fully sampled case and 10x k-t
PCA, but less perceptible in 10x k-t SPARSE-SENSE.
MBF estimation in the segment affected by ischemia
yielded MBF = 0.46 mL/g/min for R = 1, 0.45 mL/g/min
for 10x k-t PCA and 0.73 mL/g/min for 10x k-t
SPARSE-SENSE. Due to the transmural averaging of
myocardial signal including sub-endocardial ischemic
and epicardial healthy voxels, the resulting MBF is
larger than zero.
In-vivo images comparing 10x accelerated k-t PCA
and k-t SPARSE-SENSE are illustrated in Fig. 9. Five dif-
ferent slices from apex to base are displayed at time
points of maximum contrast enhancement in the right
ventricle, left ventricle, and myocardium. One slice was
omitted in-between slices thereby spanning nine slices.
Both images display similar contrast enhancement, but
while k-t PCA images display sharp tissue boundaries,
k-t SPARSE-SENSE images appear more blurred.
Figure 10 shows example MBF estimates derived
from in-vivo 3D k-t PCA and k-t SPARSE-SENSE im-
ages acquired with 10x undersampling. Average MBF
values across 8 slices and 6 sectors per slice in the first
volunteer were 0.93 ± 0.16 mL/g/min for k-t PCA and
Fig. 5 Myocardial (MYO) signal intensity vs. time derived from the septum in 3D MRXCAT simulations for different undersampling factors
and signal intensity errors. Myocardial curves from reconstructions using (a) k-t PCA and (b) k-t SPARSE-SENSE for fully sampled reference,
and undersampling factors R = 2, 5, 10. Baseline (dashed red) and upslope limits (solid blue) are indicated in (a,b). c-e Percentage errors as
a function of the undersampling factor in (c) baseline, (d) upslope and (e) peak signal. Error bars indicate mean and twice the standard
deviation across 10 realizations of the simulation
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1.06 ± 0.39 mL/g/min for k-t SPARSE-SENSE. For the
second volunteer shown, mean MBF and standard devi-
ations amounted to 0.86 ± 0.17 mL/g/min and 0.94 ±
0.30 mL/g/min, respectively. The larger standard devia-
tions of MBF in k-t SPARSE-SENSE appear as increased
inhomogeneity in MBF values across the Bull’s eye plots.
A summary of average MBF and standard deviations
for all volunteers is provided in Fig. 11. Volunteers were
grouped according to the first-pass perfusion techniques
to enable side by side comparison between acquisition
methods within volunteers. In addition to whole-heart
evaluation of 3D images, quantification was also per-
formed in a mid-ventricular region consisting of two
averaged slices of the 3D images. The averaged region
with effective slice thickness of 10 mm corresponded to
the 2D imaging region. This step was done to increase
comparability between 3D R = 10 and 2D MBF values.
Average MBFs ranged from 0.64 and 1.22 mL/g/min and
agreed well between methods. Ratios between mean k-t
PCA and k-t SPARSE-SENSE MBF ranged from 0.88 to
1.08. Comparison between accelerated k-t and 2D R = 1
methods yielded factors of 0.88 to 1.30 for k-t PCA and
0.90 to 1.14 for k-t SPARSE-SENSE. MBF standard devia-
tions within volunteers normalized to the corresponding
mean MBF were 16.3 ± 4.7% for 2D, 25.2 ± 5.5% for 10x
Fig. 7 Average MBF errors and standard deviations in % across 48
myocardial regions (8 slices, 6 angular sectors) of the MRXCAT numerical
simulation for undersampling factors R = 2, 5, 10 using k-t PCA and k-t
SPARSE-SENSE. Strong MBF underestimation occurs upon quantification
at R = 10 when the AIF and the myocardial signal intensity-time curves
are extracted from the same image upon undersampling. The MBF
errors are markedly reduced if the reference AIF is used. In this study,
the reference AIF is extracted from a separate image acquired using
interleaved scanning
Fig. 6 Percentage error upon MBF estimation for different realizations of the MRXCAT simulation. a Quantification errors in % for k-t PCA and k-t
SPARSE-SENSE at undersampling rates R = 2, 5, 10 using AIF and myocardial curves extracted from the undersampled data. Note that colour axes
for R = 10 were adjusted to portray the strong MBF underestimation. b Quantification errors [%] as in (a), derived using a reference AIF extracted
from fully sampled data and myocardial curves from the undersampled data, as accomplished using dual-sequence acquisition. The strong MBF
underestimation at R = 10 is reduced with the reference AIF
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k-t PCA, and 32.5 ± 3.2% for 10x k-t SPARSE-SENSE.
MBF standard deviations were higher in accelerated 3D
scans than in fully sampled 2D images. Comparison of
the two accelerated methods yielded lower MBF variation
in k-t PCA than k-t SPARSE-SENSE.
Discussion
The feasibility of MBF estimation from highly under-
sampled first-pass myocardial perfusion MRI has been
investigated and presented in this work. Effects were
examined by means of k-f space based MTFs, image-
Fig. 8 Example 3D MRXCAT simulation images for healthy and ischemic situations, and MBF quantification of the small sub-endocardial ischemia,
for (a) full sampling, (b) 10-fold accelerated k-t PCA, (c) 10x k-t SPARSE-SENSE. 3 slices (basal, mid-ventricular, apical) at 3 time points of signal
enhancement are shown. Sub-endocardial ischemia in one mid-ventricular slice was simulated (red arrow). Quantifications for R = 1 and 10x k-t
PCA yield equally reduced MBF in the ischemic sector, while the healthy sectors remain unaffected. MBF in the ischemic sector is also lower in
k-t SPARSE-SENSE, but MBF reduction is less pronounced
Fig. 9 Example short-axis slices of in-vivo images using 10-fold accelerated k-t PCA and 10x k-t SPARSE-SENSE perfusion imaging in one volunteer.
Time frames of peak contrast enhancement in the right ventricle, left ventricle and myocardium are shown in 5 slices from base to apex (gap of 1 slice
between the shown slices)
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time domain analysis of signal intensity, and by decon-
volution using Fermi function modelling for MBF esti-
mation. The MRXCAT framework [53] was employed
for simulation, and complemented by in-vivo assessment
of perfusion using accelerated 3D k-t PCA, 3D k-t
SPARSE-SENSE and fully sampled 2D reference data.
The concept of the MTF describing the relationship
between an imaged object and its image has been adapted
to portray undersampled first-pass perfusion CMR.
Thereby, the MTF represents the relationship in k-f space
between the fully sampled and the undersampled data
upon image reconstruction. Implementation in MRXCAT
allowed for quantification of errors relating the accelerated
imaging simulation to the corresponding fully sampled
reference. The reduction in MTF area with increasing
acceleration factor and the appearance of noise therein
provide insights into the performance of the undersam-
pling and reconstruction strategy.
For k-t PCA, the ky-f portion with MTF close to 1
remains almost unchanged from R = 2 up to R = 10, sug-
gesting adequate performance of image reconstruction
at all examined R. The increased noise-like patterns in
10x k-t PCA MTFs indicate that this acceleration factor
is close to the maximum achievable R without major loss
of data fidelity. On the other hand, k-t SPARSE-SENSE
MTFs exhibit larger non-zero areas for all temporal fre-
quencies further away from the spatial DC. MTF shapes
at R = 2 and R = 5 are similar, but a sudden drop-off at
high ky is observed at R = 10, indicating that data at
higher spatial frequencies are not properly restored. This
yields a loss in effective spatial resolution, which can be
observed in-vivo comparing k-t PCA and k-t SPARSE-
SENSE images in Fig. 9.
Starting from the original definition of the MTF as a
relationship between the object and its image, the MTF
may assume values between 0 and 1 because information
about the object is only lost and never gained with ban-
dlimited, linear imaging methods. However, when applied
to the characterization of undersampling, MTF > 1 is
possible indicating noise amplification at the corre-
sponding k-f position by regularized reconstruction.
This phenomenon is most prominent at high under-
sampling rates, e.g. in the ky-f MTF map for 10x k-t
PCA. Around spatial DC, some temporal frequencies
Fig. 10 Example in-vivo MBF estimation results comparing k-t PCA
and k-t SPARSE-SENSE in two volunteers. Mean MBFs and standard
deviations across different myocardial regions are lower for k-t PCA
than for k-t SPARSE-SENSE
Fig. 11 Summary of in-vivo myocardial blood flow (MBF) values.
a Grouped comparison of mean MBF ± standard deviation and (b)
intra-volunteer variation across sectors within 10 volunteers. Two
out of the three acquisition types (10× 3D k-t PCA, 10× 3D k-t
SPARSE-SENSE, 2D R = 1) were performed in each volunteer. For 3D
vs. 2D comparisons, a mid-ventricular region of the 3D volume
corresponding to the 2D imaging slice was additionally evaluated,
indicated by (slice). Intra-volunteer MBF variation was lower in fully
sampled cases than in accelerated CMR, and lower in k-t PCA than
in k-t SPARSE-SENSE
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exceed 1 resulting in the noise-like MTF appearance. In
contrast, MTF values vastly exceeding 1, as observed only
in k-t SPARSE-SENSE MTF maps at higher ky, may not be
explained by noise amplification alone. Presumably, these
errors stem from the treatment of non-linear com-
pressed sensing reconstruction with the linear MTF for-
malism. The assumption of linearity between images
from fully sampled and undersampled acquisitions is vio-
lated at higher frequencies, which is in line with previous
statements [41]. The discrepancy between linear and non-
linear reconstruction algorithms treated with the MTF
formalism was corrected for using masking with a fixed
threshold in the signal-to-artefact map.
Simulated signal intensity-time curves from the blood
pool and the myocardium were examined at all acceleration
factors R. The AIFs for different R agree well when
upslopes and peak signal are compared, as well as for the
baseline up to R = 5. Underestimation of the baseline at
R = 10 is most prominent in k-t PCA with almost 20%
error. The myocardial curves up to R = 5 agree well
with the reference, but exhibit deviations from ground
truth at the beginning (k-t PCA) or at the end of the
baseline (k-t SPARSE-SENSE). These errors are reflected
in the myocardial baseline error, which can be reduced if
the time frames selected for baseline averaging are opti-
mally chosen. Based on these findings, the first time
frames might be excluded when determining the baseline
in k-t PCA. Accordingly, for k-t SPARSE-SENSE, the last
time points before contrast agent arrival should be dis-
carded. The septum was chosen for myocardial signal-
time analysis due to its strategic position between the
right and left ventricle. Aliasing of components from left
and right ventricles and the myocardium is expected in
the septum upon undersampling, as these three compart-
ments are aligned along the fold-over direction. Resolving
the aliased data at this location should be more challen-
ging than anywhere else in the myocardium [17].
The percentage errors upon MBF quantification using
AIFs extracted from the undersampled image and from
a fully sampled reference were compared. Global MBF
underestimation up to 43% was observed at R = 10 with
the AIF from undersampled data, an error not present
when using the AIF from reference image. This finding
indicates that the AIF baseline error may be the main
source of inaccuracy. A remedy to address this issue in-
vivo is interleaved AIF acquisition at small acceleration
factors using dual-sequence imaging, thereby markedly
reducing the AIF baseline error. Exact knowledge of se-
quence parameters included in the corresponding signal
model was assumed in this simulation, alongside with
perfect saturation efficiency. As previously shown, errors
in parameter estimation as well as inefficient saturation
may additionally distort the estimated MBF [54]. In
addition, signal intensity to concentration non-linearity
effects may further degrade quantification accuracy for
single-sequence acquisition schemes.
Identification of sub-endocardial ischemia is a key cri-
terion for the clinical utility of novel myocardial perfu-
sion scan and post-processing methodology. MRXCAT
simulations of fully sampled and 10x accelerated imaging
including a small ischemic lesion were performed to
investigate this question. Quantification of 10x k-t PCA
data yielded MBF values in good agreement with the
fully sampled reference both in healthy and ischemic re-
gions. In contrast, MBF values derived from the 10x k-t
SPARSE-SENSE differed from the reference in healthy
segments, with increased MBF variation. In the ischemic
territory MBF reduction due to ischemia was less pro-
nounced than in the reference. This latter effect may be
related to the loss of effective spatial resolution observed
in 10x k-t SPARSE-SENSE MTF analysis.
In-vivo data were measured using a dual-sequence
acquisition framework enabling separate images map-
ping blood pool and myocardial enhancement [27]. For
3x k-t PCA the AIF baseline error remained below 2% as
confirmed by our simulations up to R = 5. In addition,
dual-sequence imaging enabled separately optimized
saturation delays for the interleaved scans, thereby
eliminating the signal vs. concentration non-linearity
concerns.
The range of average MBF values found in-vivo at rest
was in line with previous findings. Variations of MBF
across different volunteers are expected based on
physiological differences. The change in mean MBF be-
tween different acquisition techniques is lower than the
intra-volunteer MBF variation, and standard deviations
in MBF around 20% compare well to previous work.
This variation represents a persistent limitation of MBF
quantification in part caused by the ill-posed nature of
deconvolution fitting [49]. The increased intra-volunteer
variation observed in highly accelerated vs. fully sampled
reference data can be explained in part by the loss in
data fidelity and SNR caused by undersampling. To
enhance MBF estimation precision, increasing the
contrast-to-noise ratio by high dose first-pass imaging is
an option [27]. Furthermore, parallel imaging with up to
32 receive channels has been demonstrated to enhance
image quality [55]. Moreover, in accelerated first-pass
perfusion CMR accurate segmentation of the myocar-
dium is crucial. For instance, the sector-wise myocardial
signal intensity-time curve in the septum may be se-
verely distorted if a single voxel from the right ventricle
or multiple voxels affected by partial volume effects are
included in the segmentation. These challenges need to
be addressed in order to adopt fully quantitative perfu-
sion CMR in clinical routine.
In addition to solving the aforementioned implementa-
tion challenges, further validation is needed before clinical
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introduction of the proposed methods. Future studies
could include patients with sub-endocardial ischemia to
investigate the ability to detect small, localized lesions. In
addition, patients with triple vessel disease or micro-
vascular disease potentially benefit from quantitative
methods and may be included in clinical studies. In
these pathologies, healthy remote myocardium may be
absent as a reference for qualitative or semi-quantitative
approaches.
Conclusion
Combined modulation transfer function and signal-to-
artefact ratio analysis is a useful means of studying the
performance of accelerated 3D first-pass perfusion CMR
acquisition in a linearized regime, correctly predicting
losses in spatial and temporal resolution. Highly accel-
erated perfusion CMR enables estimation of myocardial
blood flow provided an unbiased arterial input function
is acquired, e.g. using dual-sequence acquisition. The
accuracy of blood flow quantification from under-
sampled imaging is maintained compared to fully sampled
reference images, whereas the precision measured by
intra-volunteer variation is reduced prompting for further
improvements of whole-heart 3D perfusion imaging
approaches.
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